Loading...
XNAS
SCNX
Market cap647kUSD
Jul 10, Last price  
0.37USD
1D
0.48%
1Q
0.00%
Jan 2017
-99.20%
IPO
-99.71%
Name

TRxADE Health Inc

Chart & Performance

D1W1MN
XNAS:SCNX chart
P/E
P/S
1.50
EPS
Div Yield, %
405.30%
Shrs. gr., 5y
212.65%
Rev. gr., 5y
-52.10%
Revenues
432k
+215.87%
000806,047955,8811,496,2272,912,5252,481,8662,931,2803,831,7787,436,26417,122,5209,889,43310,250,1681,363,830136,643431,609
Net income
-42m
L
-8,725-28,186-28,497,000-150,713-2,091,285-2,012,043-1,117,183-2,760,125288,9839,038-284,428-2,536,051-5,315,883-3,472,099-17,843,5749,065,798-41,512,264
CFO
-13.38b
L+93,711.83%
-6,225-16,068-28,164-163,118-844,579-1,064,576-1,973,776-1,313,418171,670273,386141,775-2,214,786-2,566,226-1,564,668-2,225,192-14,265,239-13,382,482,000
Dividend
Jul 19, 20241.5 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

As a health services IT enterprise, TRxADE HEALTH, Inc. manages an online platform designed to facilitate transactions between licensed pharmaceutical wholesalers and healthcare providers. This digital marketplace enables wholesalers to distribute a broad spectrum of products and services, encompassing branded and generic drugs as well as other non-pharmaceutical items. Customers for these offerings span government organizations, hospitals, medical clinics, and independent pharmacies. The firm's corporate base is situated in Tampa, Florida.
IPO date
Feb 18, 2020
Employees
33
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT